Hot content from Bone Marrow Transplantation

Click here if this e-mail doesn't display properly Official journal of the European Group for Blood and Marrow Transplantation Providing researchers and clinicians with high-quality research covering all aspects of basic biology and clinical use of hemopoietic stem cell transplantation See what your colleagues have been publishing European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update J. Maertens, O. Marchetti et al. Development and validation of a decision-making algorithm to guide the use of plerixafor for autologous hematopoietic stem cell mobilization L.J. Costa, E.T. Alexander et al. Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease M.E. McPherson, D. Hutcherson et al. Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients B.L. McClune, L.E. Polgreen et al. Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data R.F. Duarte, B.E. Shaw et al. Why submit your paper to Bone Marrow Transplantation? Highest quality – Bone Marrow Transplantation is committed to providing the most significant original research. 2011 Impact Factor 3.746*. Quick and easy online submission. Articles are published online within 25 days via Advance Online Publication. An enhanced search tool allows your paper to be identified with all other relevant Nature Publishing Group journals in all keyword searches – your paper may be found on any online search across the NPG journal websites. Papers benefit from wide readership through hosting on nature.com and inclusion in the leading abstracting and indexing services. View the guide for authors.   Never miss an article published in Bone Marrow Transplantation. *2011 Journal Citation Reports® (Thomson Reuters, 2012)  Facebook        Twitter       Google+        LinkedIn        Digg        StumbleUpon As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails or to discontinue all e-mail services from Nature Publishing Group please update your online account. Modify My Account (Log in to be recognised as a Nature.com registrant). For further information on technical assistance | print subscriptions | other enquiries. Nature Publishing Group | Principal offices: London | New York | Tokyo. Worldwide offices: Basingstoke | Boston | Buenos Aires | Delhi | Hong Kong | Madrid | Melbourne | Munich | Paris | San Francisco | Seoul | Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. Nature Publishing Group | 75 Varick St Fl 9 | New York | NY 10013-1917 | USA © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.